SCHEMBL16827378

SCHEMBL16827378

COc1ccc2c(c1)CCN(c1ccc(CC3CC3)cc1)C2=O

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP24A1 Q07973 3/20 0.49
▸ CYP26A1 O43174 2/20 0.49
▸ AOC3 Q16853 7/20 0.47
▸ CYP19A1 P11511 3/20 0.47
▸ SIGMAR1 Q99720 3/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ DRD2 P14416 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ HTR2C P28335 1/20 0.42
▸ HTR2B P41595 1/20 0.42
▸ CCR3 P51677 1/20 0.42
▸ CCR5 P51681 1/20 0.42
▸ CYP27A1 Q02318 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16848194 0.84 AOC3 (0.49) CYP24A1CYP26A1AOC3NPC1PKM
SCHEMBL16848246 0.83 AOC3 (0.48) CYP24A1CYP26A1AOC3SIGMAR1NPC1
SCHEMBL16827555 0.83 AOC3 (0.48) CYP24A1CYP26A1AOC3SIGMAR1NPC1
SCHEMBL16848068 0.82 AOC3 (0.47) AOC3NPC1PKMRAB9AHTR2A
SCHEMBL16827418 0.82 AOC3 (0.47) AOC3SIGMAR1NPC1PKMRAB9A
SCHEMBL16848202 0.82 AOC3 (0.61) AOC3NPC1PKMRAB9ADRD2
SCHEMBL16827580 0.81 AOC3 (0.46) CYP24A1CYP26A1AOC3SIGMAR1NPC1
SCHEMBL16848070 0.81 AOC3 (0.46) AOC3SIGMAR1NPC1PKMRAB9A
SCHEMBL29438611 0.81 PDE4A (0.55) AOC3NPC1PKMRAB9A
SCHEMBL29438613 0.81 PDE4A (0.55) AOC3NPC1PKMRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015092634-A1 1,2,3,4-TETRAHYDROISOQUINOLINE COMPOUNDS AND COMPOSITIONS AS SELECTIVE ESTROGEN RECEPTOR ANTAGONISTS AND DEGRADERS NOVARTIS AG (CH) 2015-06-25 — — WO disclosed
Send feedback